Thiadiazole inhibitors: a patent review

KM Dawood, TA Farghaly - Expert opinion on therapeutic patents, 2017 - Taylor & Francis
Introduction: Four isomeric structures of thiadiazole motifs have outstanding
pharmacological inhibitory applications are reported in this review. Thiadiazole nucleus is …

Contribution of Knoevenagel condensation products toward the development of anticancer agents: An updated review

R Tokala, D Bora, N Shankaraiah - ChemMedChem, 2022 - Wiley Online Library
Knoevenagel condensation is an entrenched, prevailing, prominent arsenal following
greener principles in the generation of α, β‐unsaturated ketones/carboxylic acids by …

Imidazo [2, 1-b][1, 3, 4] thiadiazoles with antiproliferative activity against primary and gemcitabine-resistant pancreatic cancer cells

S Cascioferro, GL Petri, B Parrino, D Carbone… - European journal of …, 2020 - Elsevier
A new series of eighteen imidazo [2, 1-b][1, 3, 4] thiadiazole derivatives was efficiently
synthesized and screened for antiproliferative activity against the National Cancer Institute …

Kaempferol attenuates liver fibrosis by inhibiting activin receptor–like kinase 5

T Xu, S Huang, Q Huang, Z Ming… - Journal of Cellular …, 2019 - Wiley Online Library
Liver fibrosis is a common public health problem. Patients with liver fibrosis are more likely
to develop cirrhosis, or hepatocellular carcinoma (HCC) as a more serious consequence …

Synthesis, anticancer evaluation, and molecular docking studies of some novel 4, 6-disubstituted pyrazolo [3, 4-d] pyrimidines as cyclin-dependent kinase 2 (CDK2) …

S Cherukupalli, B Chandrasekaran, V Kryštof… - Bioorganic …, 2018 - Elsevier
Abstract A novel series of 4, 6-disubstituted pyrazolo [3, 4-d] pyrimidines (7–43) bearing
various anilines at C-4 position and thiophenethyl or thiopentane moieties at C-6 position …

3-(6-Phenylimidazo [2,1-b][1,3,4]thiadiazol-2-yl)-1H-Indole Derivatives as New Anticancer Agents in the Treatment of Pancreatic Ductal Adenocarcinoma

S Cascioferro, G Li Petri, B Parrino, B El Hassouni… - Molecules, 2020 - mdpi.com
A new series of imidazo [2, 1-b][1, 3, 4] thiadiazole derivatives was efficiently synthesized
and screened for their in vitro antiproliferative activity on a panel of pancreatic ductal …

Synthesis of 4, 6-disubstituted pyrazolo [3, 4-d] pyrimidine analogues: Cyclin-dependent kinase 2 (CDK2) inhibition, molecular docking and anticancer evaluation

S Cherukupalli, B Chandrasekaran, RR Aleti… - Journal of Molecular …, 2019 - Elsevier
The cyclin-dependent kinases (CDKs) play a crucial role in cell cycle progression and are
validated targets of cancer therapy. Pyrazolopyrimidines are versatile scaffolds, which have …

Synthetic and medicinal perspective of fused-thiazoles as anticancer agents

S Pawar, K Kumar, MK Gupta… - Anti-Cancer Agents in …, 2021 - ingentaconnect.com
Background: Cancer is second leading disease after cardiovascular disease. Presently,
Chemotherapy, Radiotherapy and use of chemicals are some treatments available these …

Synthesis and Antimicrobial Activity Evaluation of Imidazole‐Fused Imidazo[2,1‐b][1,3,4]thiadiazole Analogues

F Yan Guo, C Ji Zheng, M Wang, J Ai… - …, 2021 - Wiley Online Library
Three series of new imidazole‐fused imidazo [2, 1‐b][1, 3, 4] thiadiazole analogues
(compounds 20 a–g, 21 a–g, and 22 a–g) have been synthesized, and their antibacterial …

Design, synthesis and antiproliferative activity of novel heterobivalent hybrids based on imidazo [2, 1-b][1, 3, 4] thiadiazole and imidazo [2, 1-b][1, 3] thiazole scaffolds

R Romagnoli, PG Baraldi, F Prencipe… - European Journal of …, 2015 - Elsevier
Heterobivalent ligands constituted by two different pharmacophores that bind to different
molecular targets or to two distinct sites on the same molecular target could be one of the …